Remove Bioinformatics Remove Development Remove Genotype Remove Life Science
article thumbnail

LabCorp Backs Resolution Bioscience’s Liquid Biopsy Test for NSCLC

XTalks

The leading global life science company is set to introduce Resolution Bio’s ctDx Lung assay , a non-invasive liquid biopsy test for patients with non-small cell lung cancer (NSCLC). The test was developed by Resolution Bioscience and the company will run test analyses in its labs.

Gene 105